Indian Journal of Urology Users online:4948  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Série histórica de mortalidade por neoplasias renais no Brasil (1996-2010)
Genesis de Souza Barbosa,Roberta de Lima,Raphael Mendonça Guimarães
Cadernos Saúde Coletiva.2012;20(4)537
[DOI]
2Winning the Fight Against Cancer
Athena HY Chew,Nagarajan Chandramouli,Ravindran Kanesvaran,Gopalakrishna N Iyer,William YK Hwang
Annals of the Academy of Medicine, Singapore.2020;49(10)779
[DOI]
3Winning the Fight Against Cancer
Iago Dillion Lima Cavalcanti
Annals of the Academy of Medicine, Singapore.2022;49(10)201
[DOI]
4Bilateral Metachronous Adrenal Metastases of Operated Renal Cell Carcinoma
Hakan Ozturk,Inanç Karapolat,Ali Saklamaz
Urologia Journal.2015;82(2)114
[DOI]
5Bilateral Metachronous Adrenal Metastases of Operated Renal Cell Carcinoma
Syed Wadood Ali Shah,Mohammad Shoaib,Mehreen Ghias,Muhammad Naeem Ahmed,Abdul Hameed,Ismail Shah
Urologia Journal.2020;82(2)85
[DOI]
6PPM1M and PRICKLE2 are potential tumor suppressor genes in human clear-cell renal cell carcinoma
E. E. Rudenko,G. V. Gerashchenko,Y. V. Lapska,S. O. Vozianov,Y. M. Zgonnyk,V. I. Kashuba
Biopolymers and Cell.2014;30(3)229
[DOI]
7Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Revati Sharma,Elif Kadife,Mark Myers,George Kannourakis,Prashanth Prithviraj,Nuzhat Ahmed
Journal of Experimental & Clinical Cancer Research.2021;40(1)229
[DOI]
8miR-5590-3p inhibits the proliferation and metastasis of renal cancer cells by targeting ROCK2 to inhibit proliferation, migration and invasion
Queling Liu,Anyi Zhu,Weiyin Gao,Fu Gui,Yan Zou,Xiaocheng Zhou,Zhengdong Hong
Oncology Letters.2022;24(4)229
[DOI]
9Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy
Wen Cai,Wen Kong,Baijun Dong,Jin Zhang,Yonghui Chen,Wei Xue,Yiran Huang,Lixin Zhou,Jiwei Huang
Clinical Genitourinary Cancer.2017;15(3)e437
[DOI]
10Immuntherapie in der Onkologie
Thorsten Füreder
Wiener klinische Wochenschrift Education.2017;12(1-4)17
[DOI]
11Cytoreductive nephrectomy in the era of targeted therapies: a review
Nisha Pindoria,Nicholas Raison,Gideon Blecher,Rick Catterwell,Prokar Dasgupta
BJU International.2017;120(3)320
[DOI]
12Response of Primary Renal Cell Carcinoma to Systemic Therapy
Dominick Bossé,Xun Lin,Ronit Simantov,Aly-Khan A. Lalani,Ithaar Derweesh,Steven L. Chang,Toni K. Choueiri,Rana R. McKay
European Urology.2019;76(6)852
[DOI]
13Genomics and epigenomics of clear cell renal cell carcinoma: Recent developments and potential applications
Malgorzata Rydzanicz,Tomasz Wrzesinski,Hans A.R. Bluyssen,Joanna Wesoly
Cancer Letters.2013;341(2)111
[DOI]
14Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line
Mohammed I. Khan,Konrad J. Debski,Michal Dabrowski,Anna M. Czarnecka,Cezary Szczylik
American Journal of Physiology-Renal Physiology.2016;311(2)F424
[DOI]
15Renal cell carcinoma with isolated breast metastasis
Sarah M Dhannoon,Ali A Alsaad,Abdo R Asmar,Fuad H Shahin
BMJ Case Reports.2017;311(2)bcr-2016-219124
[DOI]
16Heterozygous deletions are main cause of expression alterations of PPM1M and PRICLE2 genes in human clear cell renal cell carcinomas
E. E. Rudenko,Y. V. Lapska,G. V. Gerashchenko,E. O. Stakhovsky,M. V. Vikarchuk,V. I. Kashuba
Biopolymers and Cell.2015;31(1)29
[DOI]
17Dysregulation of microRNAs and renin-angiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats
Venkateswara Rao Amara,Sunil Kumar Surapaneni,Kulbhushan Tikoo,Michael Bader
PLOS ONE.2017;12(7)e0180490
[DOI]
18Transforming growth factor-ß promotes aggressiveness and invasion of clear cell renal cell carcinoma
Raviprakash T. Sitaram,Pramod Mallikarjuna,Maréne Landström,Börje Ljungberg
Oncotarget.2016;7(24)35917
[DOI]
19Transforming growth factor-ß promotes aggressiveness and invasion of clear cell renal cell carcinoma
Shivashankar Damodaran,E. Jason Abel
Oncotarget.2019;7(24)247
[DOI]
20Outcomes of starting low-dose pazopanib in patients with metastatic renal cell carcinoma who do not meet eligibility criteria for clinical trials
Jun Akatsuka,Go Kimura,Kotaro Obayashi,Kotaro Tsutsumi,Masato Yanagi,Yuki Endo,Hayato Takeda,Tatsuro Hayashi,Yuka Toyama,Yasutomo Suzuki,Tsutomu Hamasaki,Yoichiro Yamamoto,Yukihiro Kondo
Urological Science.2021;32(3)104
[DOI]
21Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib
Elizabeth MacLean,Jack Mardekian,Laura A. Cisar,Caroline J. Hoang,James Harnett
Journal of Managed Care & Specialty Pharmacy.2016;22(8)979
[DOI]
22Metastatic renal cell carcinoma involving colon with unusual histologic features and diagnostic challenges: A case report
Ramin Saadaat,Ahmed Maseh Haidary,Abdul Sami Ibrahimkhil,Jamshid Abdul-Ghafar
International Journal of Surgery Case Reports.2021;80(8)105627
[DOI]
23Choice of Surgical Options in Kidney Cancer and Surgical Complications
Meredith Wasserman,David Sobel,Gyan Pareek
Seminars in Nephrology.2020;40(1)42
[DOI]
24Choice of Surgical Options in Kidney Cancer and Surgical Complications
Mamta Parikh,Jerad Harris,Sigfred Ian Alpajaro,Primo N. Lara,Christopher P. Evans
Seminars in Nephrology.2020;40(1)437
[DOI]
25Metastatic renal cell carcinoma to pancreas and gastrointestinal tract: a clinicopathological study of 3 cases and review of literature
Jamshid Abdul-Ghafar,Nasir Ud Din,Ramin Saadaat,Zubair Ahmad
BMC Urology.2021;21(1)437
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us